AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
ALLOGENEIC CELL-MEDIATED IMMUNOTHERAPY FOR BREAST-CANCER AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - A CLINICAL PILOT-STUDY
Authors: OR R ACKERSTEIN A NAGLER A KAPELUSHNIK J NAPARSTEK E SAMUEL S AMAR A BRUATBAR C SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED IMMUNOTHERAPY FOR BREAST-CANCER AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - A CLINICAL PILOT-STUDY, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 1-6
ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION
Authors: OR R ACKERSTEIN A NAGLER A AMAR A NAPARSTEK E VARADI G KAPELUSHNIK J SAMUEL S PUGATSCH T BRAUTBAR C SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION, Journal of immunotherapy, 21(6), 1998, pp. 447-453
MATCHED UNRELATED HUMAN UMBILICAL-CORD BLOOD TRANSPLANTATION FOR X-LINKED ADRENOLEUKODYSTROPHY
Authors: KAPELUSHNIK J VARADI G NAGLER A
Citation: J. Kapelushnik et al., MATCHED UNRELATED HUMAN UMBILICAL-CORD BLOOD TRANSPLANTATION FOR X-LINKED ADRENOLEUKODYSTROPHY, Journal of pediatric hematology/oncology, 20(3), 1998, pp. 257-259
DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR
Authors: AKER M KAPELUSHNIK J PUGATSCH T NAPARSTEK E BENNERIA S YEHUDA O AMAR A NAGLER A SLAVIN S OR R
Citation: M. Aker et al., DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR, Journal of pediatric hematology/oncology, 20(2), 1998, pp. 145-148
BONE-MARROW TRANSPLANTATION FROM A CADAVERIC DONOR
Authors: KAPELUSHNIK J AKER M PUGATSCH T SAMUEL S SLAVIN S
Citation: J. Kapelushnik et al., BONE-MARROW TRANSPLANTATION FROM A CADAVERIC DONOR, Bone marrow transplantation, 21(8), 1998, pp. 857-858
LONG-TERM IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA)FOR MULTIPLE-MYELOMA PATIENTS FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)
Authors: ACKERSTEIN A NAGLER A NAPARSTEK E KAPELUSHNIK J VARADI G SLAVIN S OR R
Citation: A. Ackerstein et al., LONG-TERM IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA)FOR MULTIPLE-MYELOMA PATIENTS FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT), Bone marrow transplantation, 21, 1998, pp. 708-708
RECOVERY OF CELLULAR-IMMUNITY FOLLOWING HAPLOIDENTICAL STEM-CELL TRANSPLANTATION IN A PATIENT WITH SCID WITHOUT ENGRAFTMENT
Authors: LEVY J AMMAR A KAPELUSHNIK J
Citation: J. Levy et al., RECOVERY OF CELLULAR-IMMUNITY FOLLOWING HAPLOIDENTICAL STEM-CELL TRANSPLANTATION IN A PATIENT WITH SCID WITHOUT ENGRAFTMENT, Molecular immunology, 35(11-12), 1998, pp. 772-772
USE OF FIBEROPTIC BRONCHOSCOPY IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: GLAZER M BREUER R BERKMAN N LOSSOS IS KAPELUSHNIK J NAGLER A NAPARSTEK E KRAMER MR LAFAIR J ENGELHARD D OR R
Citation: M. Glazer et al., USE OF FIBEROPTIC BRONCHOSCOPY IN BONE-MARROW TRANSPLANT RECIPIENTS, Acta haematologica, 99(1), 1998, pp. 22-26
IMPAIRED LIVER-FUNCTION TESTS IN PATIENTS TREATED WITH ANTITHYMOCYTE GLOBULIN - IMPLICATION FOR LIVER-TRANSPLANTATION
Authors: TOREN A ILAN Y OR R KAPELUSHNIK J NAGLER A
Citation: A. Toren et al., IMPAIRED LIVER-FUNCTION TESTS IN PATIENTS TREATED WITH ANTITHYMOCYTE GLOBULIN - IMPLICATION FOR LIVER-TRANSPLANTATION, Medical oncology, 14(3-4), 1997, pp. 125-129
AMELOGENIN AS MARKER FOR BONE-MARROW ENGRAFTMENT - A SHORT-TERM STUDY
Authors: PUGATSCH T OR R SLAVIN S KAPELUSHNIK J
Citation: T. Pugatsch et al., AMELOGENIN AS MARKER FOR BONE-MARROW ENGRAFTMENT - A SHORT-TERM STUDY, Journal of tumor marker oncology, 12(4), 1997, pp. 47-51
NON MYELOABLATIVE CONDITIONING IN PREPARATION FOR ALLOGENEIC STEM-CELL TRANSPLANTATION - THE FUTURE TREATMENT OF CHOICE OF HEMATOLOGIC MALIGNANCIES AND GENETIC-DISEASES
Authors: SLAVIN S NAGLER A NAPARSTEK E KAPELUSHNIK J VARADI G KIRSCHBAUM M HUSSIEN A ACKERSTEIN A OR R
Citation: S. Slavin et al., NON MYELOABLATIVE CONDITIONING IN PREPARATION FOR ALLOGENEIC STEM-CELL TRANSPLANTATION - THE FUTURE TREATMENT OF CHOICE OF HEMATOLOGIC MALIGNANCIES AND GENETIC-DISEASES, Experimental hematology, 25(8), 1997, pp. 204-204
SHOULD SOYBEAN AGGLUTININ PURGING BE PERFORMED IN BREAST-CANCER PATIENTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF 48 PATIENTS
Authors: BENYOSEF R OR R NAPARSTEK E KAPELUSHNIK J SAMUELS S SLAVIN S NAGLER A
Citation: R. Benyosef et al., SHOULD SOYBEAN AGGLUTININ PURGING BE PERFORMED IN BREAST-CANCER PATIENTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF 48 PATIENTS, American journal of clinical oncology, 20(4), 1997, pp. 419-423
A FLUDARABINE-BASED PROTOCOL FOR BONE-MARROW TRANSPLANTATION IN FANCONI ANEMIA
Authors: KAPELUSHNIK J OR R SLAVIN S NAGLER A
Citation: J. Kapelushnik et al., A FLUDARABINE-BASED PROTOCOL FOR BONE-MARROW TRANSPLANTATION IN FANCONI ANEMIA, Bone marrow transplantation, 20(12), 1997, pp. 1109-1110
IMPLICATIONS OF DONOR LYMPHOCYTE INFUSION (DLI) ON ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) TOLERANCE IN PATIENTS IN RELAPSE VS. REMISSION POST MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: NAGLER A ACKERSTEIN A NAPARSTEK E OR R KAPELUSHNIK J SAMUEL S SLAVIN S
Citation: A. Nagler et al., IMPLICATIONS OF DONOR LYMPHOCYTE INFUSION (DLI) ON ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) TOLERANCE IN PATIENTS IN RELAPSE VS. REMISSION POST MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 4470-4470
NORMALIZATION OF SERUM LACTIC-DEHYDROGENASE IN BETA-THALASSEMIA PATIENTS FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: TOREN A OR R KAPELUSHNIK J CHIVIDALLI G AKU M SLAVIN S NAGLER A
Citation: A. Toren et al., NORMALIZATION OF SERUM LACTIC-DEHYDROGENASE IN BETA-THALASSEMIA PATIENTS FOLLOWING BONE-MARROW TRANSPLANTATION, American journal of hematology, 51(2), 1996, pp. 166-167
IMMUNOTHERAPY OF MALIGNANT HEMATOLOGICAL DISEASES BY ALLOGENEIC BLOOD-LYMPHOCYTES
Authors: SLAVIN S NAPARSTEK E NAGLER A KAPELUSHNIK J VARADI G KIRSCHBAUM M BENYOSEF R
Citation: S. Slavin et al., IMMUNOTHERAPY OF MALIGNANT HEMATOLOGICAL DISEASES BY ALLOGENEIC BLOOD-LYMPHOCYTES, Experimental hematology, 24(9), 1996, pp. 352-352
THE EFFECT OF POST TRANSPLANT ADMINISTRATION OF DONOR LYMPHOCYTES ON PREVENTION OF LEUKEMIC RELAPSE IN T-CELL DEPLETED ALLOGENEIC BMT
Authors: NAPARSTEK E OR R NAGLER A KAPELUSHNIK J ACKERSTEIN A SAMUEL S AKER M CIVIDALLI G SLAVIN S
Citation: E. Naparstek et al., THE EFFECT OF POST TRANSPLANT ADMINISTRATION OF DONOR LYMPHOCYTES ON PREVENTION OF LEUKEMIC RELAPSE IN T-CELL DEPLETED ALLOGENEIC BMT, Experimental hematology, 24(9), 1996, pp. 613-613
ACTIVATED ALLOGENEIC CELL THERAPY (ALLO-ACT) FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) REFRACTORY TO BUFFY COAT TRANSFUSIONS POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: KAPELUSHNIK J NAGLER A OR R NAPARSTEK E ACKERSTEIN A SAMUEL S MORECKI S NABET C SLAVIN S
Citation: J. Kapelushnik et al., ACTIVATED ALLOGENEIC CELL THERAPY (ALLO-ACT) FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) REFRACTORY TO BUFFY COAT TRANSFUSIONS POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1153-1156
IN-VIVO CAMPATH-1 FOLLOWED BY T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION - A POTENTIAL NEW MODE OF THERAPY FOR HEPATITIS-ASSOCIATED SEVEREAPLASTIC-ANEMIA (SAA)
Authors: NAGLER A ILAN Y VARADI G KAPELUSHNIK J OR R
Citation: A. Nagler et al., IN-VIVO CAMPATH-1 FOLLOWED BY T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION - A POTENTIAL NEW MODE OF THERAPY FOR HEPATITIS-ASSOCIATED SEVEREAPLASTIC-ANEMIA (SAA), Bone marrow transplantation, 18(2), 1996, pp. 475-478
HYDRONEPHROSIS IN CHILDREN AFTER BONE-MARROW TRANSPLANTATION - CASE-REPORTS
Authors: KAPELUSHNIK J VERSTANDIG A OR R MERETYK S DRAKOS P NAPARSTEK E NAGLER A
Citation: J. Kapelushnik et al., HYDRONEPHROSIS IN CHILDREN AFTER BONE-MARROW TRANSPLANTATION - CASE-REPORTS, Bone marrow transplantation, 17(5), 1996, pp. 873-875
LOW-MOLECULAR-WEIGHT HEPARIN FOR THE PREVENTION OF VENOOCCLUSIVE DISEASE OF THE LIVER IN BONE-MARROW TRANSPLANTATION PATIENTS
Authors: OR R NAGLER A SHPILBERG O ELAD S NAPARSTEK E KAPELUSHNIK J CASS Y GILLIS S CHETRIT A SLAVIN S ELDOR A
Citation: R. Or et al., LOW-MOLECULAR-WEIGHT HEPARIN FOR THE PREVENTION OF VENOOCCLUSIVE DISEASE OF THE LIVER IN BONE-MARROW TRANSPLANTATION PATIENTS, Transplantation, 61(7), 1996, pp. 1067-1071
2ND TRANSPLANTATION USING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN ABETA-THALASSEMIA MAJOR PATIENT FEATURING STABLE MIXED CHIMERISM
Authors: OR R KAPELUSHNIK J NAPARSTEK E NAGLER A FILON D OPPENHEIM A AMAR A AKER M SAMUEL S SLAVIN S
Citation: R. Or et al., 2ND TRANSPLANTATION USING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS IN ABETA-THALASSEMIA MAJOR PATIENT FEATURING STABLE MIXED CHIMERISM, British Journal of Haematology, 94(2), 1996, pp. 285-287
CONDITIONING WITH NON-MYELOABLATIVE IMMUNOSUPPRESSIVE THERAPY ALONE IS ADEQUATE TO INDUCE CHIMERISM IN ALLOGENEIC TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES
Authors: KIRSCHBAUM M OR R NAGLER A NAPARSTEK E KAPELUSHNIK J VARADI G BENYOSEF R SAMUEL S AMAR A PUGATSCH T SLAVIN S
Citation: M. Kirschbaum et al., CONDITIONING WITH NON-MYELOABLATIVE IMMUNOSUPPRESSIVE THERAPY ALONE IS ADEQUATE TO INDUCE CHIMERISM IN ALLOGENEIC TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES, Blood, 88(10), 1996, pp. 3827-3827
ALLOGENEIC CELL THERAPY WITH DONOR PERIPHERAL-BLOOD CELLS AND RECOMBINANT HUMAN INTERLEUKIN-2 TO TREAT LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SLAVIN S NAPARSTEK E NAGLER A ACKERSTEIN A SAMUEL S KAPELUSHNIK J BRAUTBAR C OR R
Citation: S. Slavin et al., ALLOGENEIC CELL THERAPY WITH DONOR PERIPHERAL-BLOOD CELLS AND RECOMBINANT HUMAN INTERLEUKIN-2 TO TREAT LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 87(6), 1996, pp. 2195-2204
ASSESSMENT OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF BLOOD-SERUM AS A DIAGNOSTIC-TOOL IN BONE-MARROW TRANSPLANTATION
Authors: BERMAN E KAPELUSHNIK J SHARON I OR R ATLAN H NAGLER A
Citation: E. Berman et al., ASSESSMENT OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF BLOOD-SERUM AS A DIAGNOSTIC-TOOL IN BONE-MARROW TRANSPLANTATION, Medical oncology, 12(2), 1995, pp. 109-114
Risultati: 1-25 | 26-45